If you have breast cancer, your doctor may prescribe Aromasin for you. It’s a prescription drug that’s used in females* who have gone through menopause. Aromasin is used to treat the following in ...

CHICAGO (Reuters) - The estrogen-blocker Aromasin was found to reduce the risk of developing breast cancer by 65 percent in post-menopausal women at high risk for breast cancer, researchers said on ...

"Aromasin provided patients with improved relapse-free survival despite early study closure, unblinding and crossover in the placebo arm," said Dr. Terry Mamounas, NSABP breast committee chairman and ...

Pfizer announced new, longer-term data from the Intergroup Exemestane Study (IES) showing that women who switched to Aromasin (exemestane tablets) after taking tamoxifen for 2-3 years experienced a ...

BBC presenter Sadie Nine has been promised by her doctor that she will be prescribed the cancer drug Aromasin as soon as it becomes available. The Radio London DJ was told she had breast cancer a year ...

Postmenopausal women with hormone receptor-positive breast cancer who received Aromasin after five years of tamoxifen were 56% less likely to have a relapse of breast cancer. New data from the ...

Doctors and patients may have a new way to prevent breast cancer -- a drug that's already approved to keep it from reappearing in women who've had it. According to a new study, the hormone-blocking ...

The role of maintenance bevacizumab in patients with metastatic breast cancer treated with chemotherapy and bevacizumab upon achieving complete response or maximal radiologic response with stable ...

Exemestane (Aromasin) is an aromatase inhibitor, prescribed for advanced breast cancer in postmenopausal women who are no longer responsive to anti-estrogen therapy.It works by decreasing the amount ...

Aromasin was approved in late in 1999 for the treatment of advanced breast cancer in postmenopausal women whose tumours have stopped responding to tamoxifen. For the first quarter of this year, the ...